30 C
Vientiane
Thursday, May 22, 2025
spot_img
Home Blog Page 617

MediBeacon® Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published

  • Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.
  • The Clinical Kidney Journal in February published MediBeacon study results on measured GFR (mGFR) using relmapirazin versus estimated GFR (eGFR) for the purpose of classifying patient Chronic Kidney Disease (CKD) stages.
  • MediBeacon TGFR study results have been posted online in the February ahead of print section in the Journal of the American Society of Nephrology (JASN).

ST. LOUIS, Feb. 25, 2025 /PRNewswire/ — MediBeacon Inc. today announced the National Medical Products Administration (NMPA) in China has approved the MediBeacon® TGFR Monitor and TGFR Sensor for the assessment of kidney function in patients with normal or impaired renal function. Lumitrace® (relmapirazin) injection, categorized as a drug in China, is under review and is targeted for approval in late 2025. The transdermal GFR technology includes Lumitrace (relmapirazin) injection, a non-radioactive, non-iodinated fluorescent GFR tracer agent, which together with the TGFR Monitor and TGFR Sensor allow assessment of kidney function by measuring the clearance rate of the fluorescent agent as it leaves the body.

In 2021, the NMPA granted the TGFR Innovative Medical Device Designation. Only 10% of applications are granted this designation. Benefits of this registration route including early product promotion are considerable.

In February, the Clinical Kidney Journal published MediBeacon data in an article on Chronic Kidney Disease (CKD) stage misclassification via estimated GFR (eGFR) compared to measured GFR (mGFR) using relmapirazin. In a stable CKD population, more than one-third of the subjects had an actual mGFR (relmapirazin) that differed by at least one CKD stage from their estimated GFR (eGFR).1  Relmapirazin is indicated for use with the TGFR.

“The Clinical Kidney Journal study raises serious concerns about how chronic kidney disease is diagnosed today,” said Dr. Ira Kurtz, Chief of the Division of Nephrology at UCLA Medical Center. “Researchers found that current eGFR methods misclassified 35% of patients, leading to potentially incorrect treatments and delayed interventions.”

In the February ahead of print section in the Journal of the American Society of Nephrology (JASN), MediBeacon clinical study data from the use of transdermal detection of relmapirazin in patients with normal to impaired kidney function across a range of skin color types was posted online.2 JASN publishes high-impact research to advance the understanding and treatment of kidney diseases.3

In addition to his leadership role at UCLA Medical Center, Dr. Kurtz is active in the development of an artificial kidney and artificial intelligence in the training and practice of nephrology.

Dr. Kurtz commented that: “The study in the Journal of the American Society of Nephrology introduces a wearable, transdermal device that assesses GFR without the need for blood samples. The fluorescence-based test, developed by MediBeacon, demonstrated an exceptional correlation (r² = 0.90) with plasma mGFR across all skin types, paving the way for more equitable and accurate kidney function assessment. These two new studies have reshaped the landscape of kidney disease diagnostics, offering both a cutting-edge innovation and a stark warning about current practices. The findings underscore the urgent need for improved kidney function assessment tools, with non-invasive, point of care GFR measurement emerging as a game-changing solution.”

“Awareness of kidney disease is relatively low despite the fact that it is the 7th leading risk factor for mortality worldwide.4 MediBeacon is pleased to have the opportunity to aid in the assessment of kidney function in China,” said Steve Hanley CEO of MediBeacon. “NMPA approval is the culmination of a rigorous device application process that required close collaboration of the MediBeacon and Huadong Medicine teams. We look forward to the next phase of our partnership with Huadong Medicine and eagerly anticipate Lumitrace approval in China later this year.”

The TGFR, which includes Lumitrace (relmapirazin), was approved on January 17th by the U.S. Food and Drug Administration (FDA). MediBeacon continues development of future TGFR products including a next-generation TGFR Sensor with updated software and algorithms.

About MediBeacon Inc.
MediBeacon is a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection. MediBeacon’s use of proprietary fluorescent tracer agents coupled with transdermal detection technology focuses on providing vital and actionable measurement of organ function. MediBeacon owns over 55 granted U.S. patents and over 215 granted patents worldwide that provide extensive coverage of the MediBeacon® TGFR, including Lumitrace® injection, the sensor and algorithms, as well as other strategic uses of its proprietary pyrazine platform and sensor technology. The TGFR is approved for human use. Potential technology applications in gastroenterology, ophthalmology and surgery are in various stages of clinical development. MediBeacon is based in St. Louis, Missouri, with additional operations in Mannheim, Germany. For more information, please visit: www.medibeacon.com.

About Lumitrace® (relmapirazin) injection
Relmapirazin is a non-radioactive, non-iodinated pyrazine-based compound, which has been engineered to be inert, highly fluorescent, and have the clearance properties of a GFR tracer agent in the body. The unique photophysical characteristics of Lumitrace have been designed to enable the collection of fluorescence data via a photodetector sensor placed on the skin. Data collected by the sensor measures the change in the intensity of Lumitrace fluorescence over time and is converted into a transdermal GFR (tGFR) by proprietary algorithms. In a phase 2 investigational study mGFR deduced from Lumitrace matched that of mGFR deduced from iohexol over a range of GFR values. See the peer reviewed article published in the October 2024 issue of Kidney International by Dorshow et al.5

About MediBeacon® Transdermal GFR System (TGFR) 
The TGFR is comprised of the TGFR Sensor, TGFR Monitor, and Lumitrace® (relmapirazin), which together allow assessment of kidney function by measuring the clearance rate of the fluorescent agent as it leaves the body. The system records Lumitrace fluorescence intensity transdermally as a function of time via a sensor placed on the skin. The TGFR Sensor records 2.5 fluorescent readings per second and the TGFR Monitor will display the average session tGFR reading at the patient’s bedside or in the outpatient setting.

IMPORTANT SAFETY INFORMATION FOR TGFR (U.S. FDA)

Indication for Use:
The MediBeacon® Transdermal GFR System (TGFR) is intended to assess the Glomerular Filtration Rate (GFR) in adult patients with impaired or normal renal function by noninvasively monitoring fluorescent light emission from an exogenous tracer agent over time. This device has been validated in patients with stable renal function.

The MediBeacon® TGFR is not approved for use in patients with GFR <15 ml/min/1.73 m2, GFR >120 ml/min/1.73m2, patients on dialysis, or anuric patients. The use of this device in patients with dynamic and rapidly changing renal function has not been validated. This device is not intended to diagnose acute kidney injury (AKI).

The MediBeacon® TGFR Sensor and exogenous tracer agent, Lumitrace® injection, are single use and are only used with the MediBeacon® TGFR.

The MediBeacon® TGFR Sensor is a single use device intended to attach to the patient’s skin and excite fluorescence in Lumitrace® injection, the tracer agent, and measure the returning light intensity. The data is sent to the MediBeacon® TGFR Monitor.

Lumitrace® is an injectable exogenous fluorescent tracer indicated for use with the MediBeacon® Transdermal GFR System (TGFR) for Glomerular Filtration Rate assessment.

Contraindications:
There are no known contraindications.

Warnings and Precautions:

  • See ifu.medibeacon.com for full instructions, warnings, and cautions.
  • In clinical studies no serious or severe adverse events have been observed.
  • Lumitrace® injection has light absorbance at 266nm and 435nm, and broad fluorescent emission at ~560nm when excited at ~440nm. Any drug activated at these wavelengths should not be used in conjunction with Lumitrace.
  • Lumitrace injection may interfere with clinical laboratory tests. DO NOT ADMINISTER if the patient is expected to need clinical laboratory testing while Lumitrace is present in their system (up to 72 hours for renally-impaired patients). The presence of Lumitrace decreased B-Type Natriuretic Peptide (BNP) results by around 20% in limited testing.
  • Bolus infusions may impact the GFR assessment temporarily while the vasculature-tissue equilibrium is re-established.
  • During a TGFR session, the patient should be as still as possible, especially during the “Establishing Baseline” stage. The current system is designed to compensate for light activity such as reading or eating after the Baseline stage.

1 CKD stage misclassification between estimated GFR and measured GFR in a clinical study of chronic kidney patients, Clinical Kidney Journal,  Dorshow, Richard B. et al., 2025 Jan 9;18(2):sfaf006. DOI: 10.1093/ckj/sfaf006
2 Glomerular Filtration Rate Measurement Utilizing Transdermal Detection Methodology, Journal of the American Society of Nephrology (JASN), Dorshow, Richard B. et al., February 7, 2025, DOI: 10.1681/ASN.0000000639
3 https://www.asn-online.org/publications/
4 Chronic kidney disease and the global public health agenda: an international consensus, Nature Reviews Nephrology, 20, 473-485 (2024), doi.org/10.1038/s41581-024-00820-6
5 Clinical validation of the novel fluorescent glomerular filtration rate tracer agent relmapirazin (MB-102), Kidney International, Volume 106, Issue 4, P679-687, October 2024, DOI: 10.1016/j.kint.2024.06.012

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 25TH

NEW YORK, Feb. 25, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 25TH

Trinity Chavez delivers the pre-market update on February 25th

  • Markets await release of this morning’s Consumer Confidence Index
  • Friday’s PCE Index to provide insights on future Fed policy
  • New home sales data and jobless claims to release later this week

Watch NYSE TV Live every weekday 9:00-10:00am ET 

Video – https://mma.prnasia.com/media2/2627318/NYSE_Feb_25_Market_Update.mp4 

 

BTCS Inc. Announces Strategic Partnership and Investment in ETHGas to Grow Market Share and Support Scaling Ethereum Through Realtime Transactions

Silver Spring, Maryland – Newsfile Corp. – February 25, 2025 – BTCS Inc. (NASDAQ: BTCS) (“BTCS” or the “Company”), a leader in blockchain infrastructure and technology, is pleased to announce a strategic partnership with ETHGas, where BTCS will serve as a Priority Builder. As part of this collaboration, BTCS also made a $250,000 investment into ETHGas. This partnership and investment aligns with BTCS’s strategy to not only increase its market share but also expand the overall market size. This initiative is intended to unlock ultra-low-latency scaling on Ethereum’s blockchain, enabling transaction confirmations approximately 100 times faster than Solana.

The ETHGas investment was structured as a SAFT (Simple Agreement for Future Tokens) and designates BTCS as a Priority Builder. This exclusive role is granted to builders with proven expertise in low-latency block construction and robust order flow capabilities. As a Priority Builder, BTCS is strategically positioned to expand its influence over blockspace and grow its market share.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/11377/241789_d71ea94ab4bf0a33_002full.jpg

“As a pioneer in blockchain infrastructure and digital asset innovation, BTCS is thrilled to partner with ETHGas to expand the overall market of fee-based products, to drive revenue for BTCS while helping make Ethereum transactions more efficient and cost-effective for the ecosystem,” said Charles Allen, CEO of BTCS. “Our investment in ETHGas aligns with our strategy to drive scalable revenue growth and improve margins by expanding order flow, refining our tech stack, and controlling block space. Our planned ETHGas integration should help achieve this goal by increasing both order flow and block space.”

Cannot view this video? Visit:
https://www.youtube.com/watch?v=GPdYx3gQYQE

ETHGas re-engineers the Ethereum pipeline for block construction enabling Validators to sell blockspace in advance of the spot block auction. On one side of the marketplace, ETHGas provides certainty to Validators, and on the other side, it provides an array of precision order execution products for end-users, like traders, to customize their access to blockspace. By enabling 3 millisecond blockspace confirmations and instruments to hedge gas price volatility, ETHGas creates a real-time, gasless Ethereum, where the handling and trading of gas is largely relegated to the background among institutional players. ETHGas has partnered with builders representing over 90% of the market, and is working with the majority of validators to ensure broad network participation and adoption.

ETHGas Founder Kevin Lepsoe expressed enthusiasm, stating, “BTCS’s partnership validates our mission to open up and democratize access to blockspace. This collaboration helps pave the way for a much faster, more efficient Ethereum enabling transaction costs or ‘gas prices’ to be risk-managed within a traditional commodity risk-management framework.” He continued, “Together with BTCS, we enhance accessibility, in particular, to global Asset Managers as they look to scale their ETH and Staked ETH Fund offerings.

About BTCS:
BTCS Inc. (NASDAQ: BTCS) is a U.S.-based blockchain infrastructure technology company currently focused on driving scalable revenue growth through its blockchain infrastructure operations. BTCS has honed its expertise in blockchain network operations, particularly in block building and validator node management. Its branded block-building operation, Builder+, leverages advanced algorithms to optimize block construction for on-chain validation, thus maximizing gas fee revenues. BTCS also supports other blockchain networks by operating validator nodes and staking its crypto assets across multiple proof-of-stake networks, allowing crypto holders to delegate assets to BTCS-managed nodes. In addition, the Company has developed ChainQ, an AI-powered blockchain data analytics platform, which enhances user access and engagement within the blockchain ecosystem. Committed to innovation and adaptability, BTCS is strategically positioned to expand its blockchain operations and infrastructure beyond Ethereum as the ecosystem evolves. Explore how BTCS is revolutionizing blockchain infrastructure in the public markets by visiting www.btcs.com.

For more information follow us on:

Twitter: https://x.com/NasdaqBTCS
LinkedIn: https://www.linkedin.com/company/nasdaq-btcs
Facebook: https://www.facebook.com/NasdaqBTCS

About ETHGas
ETHGas is a blockchain technology company dedicated to institutionalizing Ethereum’s gas markets through low latency infrastructure, and a broad suite of risk management instruments. By providing structure to the gas markets, ETHGas brings certainty and predictability to validators, block builders, traders, decentralized applications (DApps) and scalability to Ethereum at large. The ETHGas Protocol Token (GASS) serves as a key component of the ecosystem providing governance to the broad set of participants that interact with blockspace on Ethereum.

For more information, visit www.ethgas.com. The information contained on, or accessible through, this website is not incorporated by reference into this press release, and you should not consider it part of this press release.

Forward-Looking Statements:
Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws, including statements regarding our ability to grow market share, drive revenue, increasing both order flow and block space and improve margins by expanding order flow. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon assumptions and are subject to various risks and uncertainties, including without limitation regulatory issues, cybersecurity risks, technological challenges, market adoption risks, competition, changes in blockchain protocols, unexpected issues with Builder+ or ChainQ, the reluctance of validators to utilize our Builder+ product, volatility in cryptocurrency markets, and other risks inherent to blockchain technology and cryptocurrency operations, as well as risks set forth in the Company’s filings with the Securities and Exchange Commission including its Form 10-K for the year ended December 31, 2023 which was filed on March 21, 2024. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements, whether as a result of new information, future events, or otherwise, except as required by law.

BTCS Investor Relations:
Charles Allen – CEO
X (formerly Twitter): @Charles_BTCS
Email: ir@btcs.com

ETHGas Public Relations:
Kevin Lepsoe – Founder
X (formerly Twitter) @lepsoe
Email: ir@ethgas.com

The issuer is solely responsible for the content of this announcement.

SunCar Technology Addresses National Automotive Circulation Industry Forum, Showcasing Digital Solutions for Dealers

NEW YORK, Feb. 25, 2025 /PRNewswire/ — SunCar Technology Group Inc. (“SunCar” or the “Company”) (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services in China, participated in the National Automotive Circulation Industry New Year Forum and Consumer Promotion Conference in Beijing. The Company, serving as a vice president unit of the National Automotive Circulation Industry Association, was represented by Vice President Gu Saiye, who delivered a keynote address highlighting SunCarOnline’s technological solutions that help dealers enhance customer retention, renewal rates, and profitability.

The conference brought together over 400 industry stakeholders, including automotive dealer groups, manufacturers, pre-owned vehicle enterprises, financial and insurance institutions, aftermarket service providers, and automotive trade association representatives from across China. Attendees examined industry development trends and consumer promotion strategies, analyzed market conditions, and discussed implementing the 2025 auto trade-in policy to stimulate the automotive consumer market.

In her presentation, Vice President Gu detailed how SunCar Technology enhances dealer competitiveness through its “SunCarInsurance” platform and showcased successful case studies integrating auto insurance into customer lifecycle management. The Company’s technological solutions enable dealers to implement seamless sales and after-sales management, improving customer retention and remarketing efficiency. SunCar’s “Car Butler” service and cloud-based customer service platform provide comprehensive dealer support while enhancing customer satisfaction and loyalty, thereby increasing renewal rates, claim rates, and service retention, all contributing to improved profitability.

“Our commitment remains focused on advancing the automotive circulation industry through technological innovation,” stated Gu Saiye. “SunCar Technology will continue strengthening our dealer partnerships, expanding our solution offerings, and supporting high-quality industry development.”

Conference participants commended SunCar Technology’s innovations in auto insurance and customer lifecycle management as setting industry standards. Multiple dealer representatives expressed interest in deepening their collaboration with SunCar Technology to accelerate digital transformation within the automotive circulation industry.

The forum established a valuable platform for industry dialogue and collaboration while outlining strategic directions for the automotive circulation industry in 2025. SunCar Technology will continue leveraging its technological capabilities and industry partnerships to address emerging opportunities and challenges.

About SunCar Technology Group Inc.

Founded in 2007, SunCar is transforming the customer journey for auto services and auto insurance in China, the largest passenger vehicle market in the world. SunCar develops and operates cloud-based platforms that seamlessly connect drivers with a wide range of auto services and insurance coverage options through a nationwide network of sales partners. As a result, SunCar has established itself as the leader in China in the B2B auto services market and the auto eInsurance market for electric vehicles. The Company’s intelligent cloud platform empowers its enterprise clients to access and manage their customer database and offerings optimally, and drivers gain access to hundreds of services from tens of thousands of independent providers in a single application. For more information, please visit https://suncartech.com.

Forward-Looking Statements

This press release contains information about the Company’s view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company encourages you to review other factors that may affect its future results in the Company’s annual reports and in its other filings with the Securities and Exchange Commission.

Contact Information:

SunCar:
Investor Relations: Ms. Hui Jiang
Email: IR@suncartech.com
Legal: Ms. Li Chen
Email: chenli@suncartech.com

U.S. Investor Relations
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

 

Foxit Supercharges AI Assistant with Multi-Document Analysis on iOS & Android

Enables Users to Boost Productivity with AI-Powered Summaries, Cross-Document Insights, and Instant Data Extraction Across Mobile Device

FREMONT, Calif., Feb. 25, 2025 /PRNewswire/ — Foxit, a leading provider of innovative PDF and eSignature products and services, helping knowledge workers to increase productivity and do more with documents, today announced the addition of multi-document analysis to its AI Assistant feature within its mobile apps for iOS and Android. This new and unique capability enhances the AI Assistant’s functionality, enabling users to analyze multiple documents simultaneously directly from their mobile devices.

The introduction of multi-document analysis caters to the evolving needs of professionals who require efficient tools to manage and process large volumes of information. The new feature is designed to simplify workflows by allowing users to:

  • Summarize Multiple Documents at Once: Create concise summaries for all uploaded documents, saving time by avoiding the need to review each individually.
  • Ask Questions Across Files: Get answers that draw insights from multiple documents simultaneously, ideal for comparing contracts, reports, or research materials.
  • Extract Key Information: Pinpoint critical data, such as deadlines or figures, or find patterns and trends from across multiple files in seconds.

Whether you’re a legal professional reviewing case files, a researcher analyzing studies, or a business leader comparing proposals, the AI Assistant’s Multi-Document Analysis feature ensures greater productivity and smarter decision-making anytime and anywhere.

The multi-document analysis feature is now available in the latest update to Foxit’s PDF Reader and PDF Editor mobile apps for iOS and Android.

“People just don’t have time to sift through a pile of documents one by one anymore… especially on their phones,” said Evan Reiss, VP, Head of Marketing, Foxit. “With multi-document analysis in our AI Assistant, you can get summaries, pull key details, and ask questions across multiple files all at once. It’s about working smarter, not harder – and making sure you have the info you need, right when you need it.”

For more information about Foxit’s AI solutions, please visit https://www.foxit.com/ai-pdf/.

About Foxit
Foxit is a leading provider of innovative PDF and eSignature products and services, helping knowledge workers to increase their productivity and do more with documents. Foxit delivers easy-to-use desktop software, mobile apps, and cloud services that allow users to create, edit, fill, and sign documents through their integrated PDF Editor and eSign offerings. Foxit enables software developers to incorporate innovative PDF technology into their applications via powerful, multi-platform Software Developer Kits (SDK).

Foxit has sold to over 640,000 customers, ranging from SMBs to global enterprises, located in more than 200 countries. The company has offices worldwide, including locations in the U.S., Europe, Australia, and Asia. For more information, please visit https://foxit.com.

PR Contact:
Nicole Gorman
Touchdown PR, for Foxit
508-397-0131
foxit@touchdownpr.com

Sustainable Mining Operations Escalate as Demand for Critical Materials Doubles by 2030

NEW YORK, Feb. 25, 2025 /PRNewswire/ — The mining sector is at the forefront of the energy transition due to its role in extracting essential materials and minerals necessary for green technologies. As demand for renewable energy, electric vehicles, and other sustainable technologies increases exponentially, so will the demand for these necessary materials. According to a new report from global technology intelligence firm ABI Research, demand for critical materials is expected to grow from 8,253 Kilotonnes (kt) in 2023 to 17,711 kt in 2030 at a CAGR of 11.5%.

“The rising demand for renewable energy and electrification technologies presents a paradox,” explains Alex McQueen, Sustainable Technologies Analyst at ABI Research. “Increasing demand for materials needed for these technologies will lead to an intensification of mining activities, contributing around 4-7% of global emissions. The challenge for mining companies today centers around meeting emission reduction expectations while increasing output of critical materials and minerals to meet consumer demand.”

The solution to this is the integration of sustainable technologies that support the decarbonization of mining operations. These include:

  • Renewables and Energy Storage: Integrating renewable energy is one of the most effective levers to decarbonize the mining sector. With around 40% of mine emissions coming from energy consumption, shifting to solar, wind, and hydroelectric power offers significant potential for emission reduction. Leading solution providers include Honeywell, GE Vernova, and Schneider Electric.
  • Digital and Automation Technologies: The mining industry is on the brink of a transformative era driven by digital technologies. Their ability to enhance productivity and safety will boost operational efficiencies and sustainability within mining operations. Technologies such as IoT, Artificial Intelligence (AI), and digital twins have become fundamental to reducing emissions at mines. Leading solution providers include Schneider Electric, Siemens, and SAP.
  • Electric Equipment and Vehicles: In addition to renewable integration, mining companies can achieve significant emission reductions through the electrification of mine vehicles and equipment and improvements in energy efficiency. Electrification may occur through the purchase of new electric vehicles or by considering retrofit options, which provides a more cost-effective alternative. Leading solution providers include ABB, Hitachi Energy, and Caterpillar.
  • Waste Management and Circularity Tools: The mining sector is key to enabling circularity by ensuring that metals and materials are extracted and managed efficiently. Reprocessing and repurposing waste help extend the life of materials, while digital technologies can support efficient waste management practices. Leading solution providers include Rockwell Automation, Dassault Systèmes, and AspenTech.

“Recognizing the critical importance of sustainable mine operations is essential for driving energy transition and sustainable growth. Technology holds significant potential in enhancing operational efficiencies and sustainability. The industry must continue to embrace innovation, collaboration, and environmental stewardship to ensure the stability and security of essential materials,” concludes McQueen.

These findings are from ABI Research’s Decarbonization Technologies for the Mining Sector report. This report is part of the company’s Sustainability for Industrial Markets research service, which includes research, data, and ABI Insights. 

About ABI Research

ABI Research is a global technology intelligence firm uniquely positioned at the intersection of technology solution providers and end-market companies. We serve as the bridge that seamlessly connects these two segments by providing exclusive research and expert guidance to drive successful technology implementations and deliver strategies proven to attract and retain customers.

ABI Research是一家全球性的技术情报公司,拥有得天独厚的优势,充当终端市场公司和技术解决方案提供商之间的桥梁,通过提供独家研究和专业性指导,推动成功的技术实施和提供经证明可吸引和留住客户的战略,无缝连接这两大主体。

For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.

Contact Info

Global
Deborah Petrara
Tel: +1.516.624.2558
pr@abiresearch.com

Captiva Verde Announces Jennifer Bellinger Joins Advisory Board

Vancouver, British Columbia – Newsfile Corp. – February 25, 2025 – Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF) (“Captiva Verde”) a public company listed on the Canadian Securities Exchange under the trading symbol PWR and further listed in the US OTC Market under the symbol CPIVF announces that Jennifer Bellinger has joined the Advisory Board of Matnaggewinu Development Corporation and Captiva Verde Wellness Corp.

Jennifer, with her strong paternal roots in the Great Sioux Nation, is a committed advocate for indigenous self-sufficiency, economic reconciliation and sustainable long-term growth.

She is an immensely dynamic multifaceted professional, relationship builder and power broker. With a diverse career as a commercial and residential realtor, former pastor, business owner, and rainmaker, she embodies a deep passion for connecting people and fostering successful connections. Jennifer has made a significant impact on every person and in every field she has entered.

Jennifer began her initial journey in education, both as a teacher and a pastor, where she honed her skills in leadership, community building, personal development and communications. Her deep-seated commitment to helping others naturally evolved into a successful career in real estate, guiding families, investors, developers and individuals through some of the most significant financial decisions of their lives. Jennifer has built a reputation for being a trusted advisor and advocate for all of her clients, leveraging her extensive network to ensure the best possible outcomes.

In addition to her work in real estate, Jennifer is also a savvy business owner. She combines an entrepreneurial spirit with a genuine desire to serve others, creating ventures that not only thrive in the marketplace but also empower those around her.

Jennifer’s influence extends beyond her business life; she is also a respected mentor and devoted mother, impressively raising a family of highly respected professional athletes. Her son Cody Bellinger, has reached the pinnacle of Major League Baseball; a 2020 world series champion, 2 x All-Star, MVP, rookie of the year, golden glove, silver slugger and currently playing for the NY Yankees. He precedes his father, Jennifer’s husband Clay Bellinger, with his two-world series wins for the NY Yankees in 1999 and 2000. This is a spectacular achievement of inspiring her family’s dedication to athletics. Another son Cole is spreading his wings as a skilled pilot, also a former pro-baseball player, while her daughter works tirelessly as a professional counselor, impacting lives through her compassionate care. Each of Jennifer’s children embodies her values of hard work, perseverance, and service, making her proud of the contributions they make both on and off the field. Jennifer is a strong advocate of fitness, healthy nutrition and lifestyle, natural remedies and service to the community.

Jennifer’s gift for networking and connecting individuals is unparalleled. She thrives on bringing people together, being it buyers and sellers, aspiring pro athletes and coaches, or professionals seeking collaboration. Through her unwavering support and innate ability to foster meaningful relationships, she continues to enrich the lives of everyone in her orbit.

Jeff Ciachurski, CEO of Captiva Verde states: “Jennifer Bellinger is more than just a successful real estate professional and power broker; she is a community leader, dedicated mother, humanitarian, visionary, and a connector of people who leaves a lasting impact wherever she goes. Through her diverse career and familial achievements, she exemplifies what it means to lead with heart and purpose. We are honored to have her as an Advisor”.

About Matnaggewinu Development Corporation (MDC):

MDC is a Mi’kmaq-led organization committed to advancing economic development for Mi’kmaq communities through sustainable projects and partnerships. The corporation focuses on initiatives that preserve Mi’kmaq culture while fostering economic self-reliance and prosperity. Matnaggewinu Development Corporation (MDC) is 49% owned by Captiva Verde.

About Captiva Verde:

Captiva is dedicated to building partnerships that support Indigenous development and economic growth in key sectors such as real estate-based hospitality, tourism, aviation and renewable resources.

On Behalf of the Board of Directors

“Jeff Ciachurski”

Jeffrey Ciachurski
Chief Executive Officer and Director
Cell: (949) 903-5906
E-mail: westernwind@shaw.ca

Neither Canadian Securities Exchange nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Information

This news release includes “forward-looking statements” and “forward-looking information” within the meaning of Canadian securities laws and United States securities laws (together, “forward-looking statements”). All statements included in this news release, other than statements of historical fact, are forward-looking statements including, without limitation, statements with respect to the expansion of Captiva’s health and wellness platform.

Forward-looking statements include predictions, projections and forecasts and are often, but not always, identified by the use of words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, “potential”, “target”, “budget”, “propose” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions and includes the negatives thereof.

Forward-looking statements are based on a number of assumptions and estimates that, while considered reasonable by management based on the business and markets in which the Company operates, are inherently subject to significant operational, economic, and competitive uncertainties, risks and contingencies. These include assumptions regarding, among other things: general business and economic conditions. There can be no assurance that forward-looking statements will prove to be accurate and actual results, and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include those described under the heading “Risks and Uncertainties” in the Company’s most recently filed MD&A (a copy of which is available under the Company’s SEDAR profile at www.sedar.com). The Company does not undertake to update or revise any forward-looking statements, except in accordance with applicable law.

The issuer is solely responsible for the content of this announcement.

Vialto Partners Completes Recapitalization Transaction

Transaction Completely and Definitively Transforms Vialto’s Capital Structure, Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of Existing Debt

NEW YORK, Feb. 25, 2025 /PRNewswire/ — Vialto Partners (“Vialto” or the “Company”), a premier provider of global mobility, tax, and immigration solutions to the world’s leading companies, announced today that it has completed its previously announced recapitalization transaction with a group consisting of its existing financial sponsor, Clayton, Dubilier & Rice (“CD&R”), and certain of its existing debt holders, including funds managed by HPS Investment Partners (“HPS”).

“The completion of this transaction is a vote of confidence by our sponsors and lenders in the kind of company we’re building,” said Neil Masterson, CEO of Vialto. “Vialto helps the world’s leading businesses unlock the potential of their people around the world. We’re home to the industry’s top experts in global workforce mobility, tax, and immigration, and we’ll continue to invest in developing innovative technologies that make us uniquely placed to advise our clients as they navigate a constantly changing world.”

The transaction delivers a $225 million new money equity capital investment in Vialto and an approximately $550 million reduction of existing debt, resulting in a more sustainable capital structure for the group going forward.

Under the transaction, CD&R continues to be the majority shareholder of Vialto and HPS is a minority equity owner.

Weil, Gotshal & Manges LLP, and Latham & Watkins LLP provided legal advice to Vialto. Evercore Group L.L.C. served as financial advisor and AlixPartners LLP acted as operational advisor to Vialto. Debevoise & Plimpton LLP and Kirkland & Ellis LLP provided legal advice to CD&R. Moelis & Company served as financial advisor to CD&R. Paul, Weiss, Rifkind, Wharton & Garrison LLP provided legal advice to HPS. Houlihan Lokey Capital, Inc. served as financial advisor to HPS. Davis Polk & Wardwell LLP and Ashurst LLP provided legal advice to the First Lien Ad Hoc Group and Guggenheim Securities, LLC served as financial advisor. Simpson Thacher & Bartlett LLP provided legal advice to JPMorgan Chase Bank, N.A., the First Lien Facility Agent, and RPA Advisors, LLC served as financial advisor. Holland & Knight LLP provided legal advice to the Second Lien Facility Agent and Bridge Facility Agent.

About Vialto Partners

Vialto Partners works with the world’s leading companies to provide the global mobility, tax, and immigration solutions that enable cross-border operations. As a trusted advisor of compliance, consulting, and technology services to multinational corporations, the firm solves complex, cross-border workforce mobility challenges to ensure its clients and their employees experience a consistent and compliant global mobility experience through Vialto’s cutting-edge technology and deep domain expertise. To learn more, visit www.vialtopartners.com.

Media Contacts:

Vialto Partners
Kal Goldberg / Kerry Golds
Vialtopartners@fgsglobal.com